Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer
Conditions: Advanced Solid Tumors; Triple Negative Breast Cancer Intervention: Drug: TT-00420 Sponsor: TransThera Biosciences Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials